Delivery Order SPE2DB20D7059-SPE2DB25FQLN8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) under a firm fixed-price contract valued at $1,947.21, with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $6,394.80 under a firm fixed-price contract. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-set-aside competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform this work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $2,557.92 under a firm fixed-price contract type. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and utilized no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $24,239.08 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on September 14, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is being...
- The Defense Logistics Agency awarded a delivery order valued at $5,791.57 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) on August 20, 2025, with completion scheduled for August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- AmerisourceBergen Drug Corp was awarded a $4,617.45 delivery order by the Defense Logistics Agency on April 24, 2025, for Vaxelis vaccine syringes (0.5mL). The contract, designated as a firm fixed-price delivery order with an ultimate completion date of April 25, 2025, will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award is unset-aside and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,836.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for Vaxelis vaccine syringes in 0.5ML quantities. The order, which is non-set-aside and competitively awarded, has an ultimate completion date of April 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $19,930.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on September 5, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,394.80 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) with an ultimate completion date of June 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on June 18, 2025. The contractor's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,958.90 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vaxelis vaccine syringes (0.5mL) with an ultimate completion date of August 13, 2025. This firm fixed price contract represents a non-set-aside award and will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQLN8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,888.38 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) with a firm fixed price structure. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by July 18, 2025, one day after the award date of July 17, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's IDC vehicle encompasses a comprehensive global pharmaceutical support program enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, medical devices, and associated supplies across multiple therapeutic domains. The current delivery order for vaccine syringes supports DLA's medical supply chain operations and aligns with the agency's broader pharmaceutical prime vendor initiative, which is planning to establish Generation V contracts with multiple regional awards to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 7/17/25 |